Advertisement
Advertisement
SERA
Sera Prognostics, Inc. Class A Common Stock
1.88
USDSponsored
-0.04
-2.08%
May 08, 15:59 UTC -4
Closed
Pre-Market
1.91
+0.03
+1.60%
SERA Earnings Reports
Positive Surprise Ratio
SERA beat 14 of 20 last estimates.
70%
Next Report
Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$112.20K
/-$0.17
Implied change from Q1 26 (Revenue/ EPS)
+1022.00%
/--
Implied change from Q2 25 (Revenue/ EPS)
+560.00%
/+6.25%
Sera Prognostics, Inc. Class A Common Stock earnings per share and revenue
On May 06, 2026, SERA reported earnings of -0.17 USD per share (EPS) for Q1 26, Inline the estimate of -0.17 USD, resulting in a 0.00% surprise. Revenue reached 10.00 thousand, compared to an expected 81.60 thousand, with a -87.75% difference. The market reacted with a +6.08% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -0.17 USD, with revenue projected to reach 112.20 thousand USD, implying an increase of 0.00% EPS, and increase of 1022.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Progyny, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.30
Actual
$0.50
Surprise
+63.99%
Omada Health, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.08
Actual
$0.01
Surprise
+112.22%
agilon health, inc.
Report Date
May 06, 2026 For Q1 26
Estimate
$0.91
Actual
$1.80
Surprise
+97.04%
The Oncology Institute, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.02
Surprise
+74.46%
SkinHealth Systems Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.05
Surprise
+36.47%
Natera, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.54
Actual
-$0.56
Surprise
-2.36%
Viatris Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.51
Actual
$0.59
Surprise
+15.17%
Charles River Laboratories International, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$1.96
Actual
$2.06
Surprise
+4.98%
Caris Life Sciences, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
$0.00
Surprise
+100.00%
Concentra Group Holdings Parent, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.34
Actual
$0.40
Surprise
+17.03%
FAQ
What were Sera Prognostics, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Sera Prognostics, Inc. Class A Common Stock reported EPS of -$0.17, missing estimates by 0%, and revenue of $10.00K, -87.75% below expectations.
How did the market react to Sera Prognostics, Inc. Class A Common Stock's Q1 2026 earnings?
The stock price moved up 6.08%, changed from $1.81 before the earnings release to $1.92 the day after.
When is Sera Prognostics, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Aug 04, 2026.
What are the forecasts for Sera Prognostics, Inc. Class A Common Stock's next earnings report?
Based on 5
analysts, Sera Prognostics, Inc. Class A Common Stock is expected to report EPS of -$0.17 and revenue of $112.20K for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement